These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 427056)

  • 1. Activity and characterization of a low molecular fraction present in human amniotic fluid with broad spectrum antibacterial activity.
    Sachs BP; Stern CM
    Br J Obstet Gynaecol; 1979 Feb; 86(2):81-6. PubMed ID: 427056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity in human amniotic fluid: relationship to zinc and phosphate.
    Scane TM; Hawkins DF
    Br J Obstet Gynaecol; 1984 Apr; 91(4):342-8. PubMed ID: 6424700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial growth inhibition by amniotic fluid. V. Phosphate-to-zinc ratio as a predictor of bacterial growth-inhibitory activity.
    Schlievert P; Johnson W; Galask RP
    Am J Obstet Gynecol; 1976 Aug; 125(7):899-905. PubMed ID: 782248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial growth inhibition by amniotic fluid. VII. The effect of zinc supplementation on bacterial inhibitory activity of amniotic fluids from gestation of 20 weeks.
    Schlievert P; Johnson W; Galask RP
    Am J Obstet Gynecol; 1977 Mar; 127(6):603-8. PubMed ID: 842586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of amniotic fluid phosphate-to-zinc ratios to post-cesarean section infection.
    Minkoff HL; Henry V; De Cresce R; Schwarz RH
    Am J Obstet Gynecol; 1982 Apr; 142(8):988-91. PubMed ID: 7072787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial growth inhibition by amniotic fluid. VI. Evidence for a zinc-peptide antibacterial system.
    Schlievert PS; Johnson W; Galask RP
    Am J Obstet Gynecol; 1976 Aug; 125(7):906-10. PubMed ID: 782249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a polyamine-peptide conjugate from human amniotic fluid.
    Seale TW; Chan WY; Shukla JB; Rennert OM
    Clin Chim Acta; 1979 Aug; 95(3):461-72. PubMed ID: 487584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid analysis for antimicrobial factors.
    Thadepalli H; Gangopadhyay PK; Maidman JE
    Int J Gynaecol Obstet; 1982 Feb; 20(1):65-72. PubMed ID: 6126410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate content of human amniotic fluid and its relationship to bacterial growth inhibition.
    Tomblin J; Davis B; Larsen B
    Am J Reprod Immunol Microbiol; 1987 Feb; 13(2):33-5. PubMed ID: 3296795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and some properties of zinc-containing proteins from human placenta.
    Milnerowicz H; Jacyszyn K; Zalewski J; Woytoń J
    Biomed Biochim Acta; 1986; 45(3):305-13. PubMed ID: 3085660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Causes of the antibacterial action of amniotic fluid (author's transl)].
    Dickgiesser N; Hohlweg-Majert P; Wuthe J
    Geburtshilfe Frauenheilkd; 1981 Jul; 41(7):504-8. PubMed ID: 6790329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Manifestations and mechanisms of the antimicrobial activity of amniotic fluid].
    Ankirskaia AS
    Akush Ginekol (Mosk); 1985 Dec; (12):5-8. PubMed ID: 2937329
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the growth-inhibiting property of amniotic fluids from two United States population groups.
    Appelbaum PC; Shulman G; Chambers NL; Simon NV; Granados JL; Fairbrother PF; Naeye RL
    Am J Obstet Gynecol; 1980 Jul; 137(5):579-82. PubMed ID: 6992582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc concentration of amniotic fluid in the course of pregnancy and its relationship to fetal weight and length.
    Durá Travé T; da Cunha Ferreira RM; Monreal I; Ezcurdia Gurpegui M; Villa-Elizaga I
    Gynecol Obstet Invest; 1984; 18(3):152-5. PubMed ID: 6489848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular weight of sodium hyaluronate in amniotic fluid.
    Dahl LB; Dahl IM; Børresen AL
    Biochem Med Metab Biol; 1986 Apr; 35(2):219-26. PubMed ID: 3707753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace elements and antibacterial activity in amniotic fluid.
    Honkonen E; Näntö V; Hyörä H; Vuorinen K; Erkkola R
    Biol Neonate; 1986; 50(1):21-6. PubMed ID: 3527280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein and peptide fribrinolysis inhibitor in human amniotic fluid].
    Uszyński M
    Ginekol Pol; 1980 Feb; 51(2):113-8. PubMed ID: 6989713
    [No Abstract]   [Full Text] [Related]  

  • 18. Inorganic phosphorus and zinc concentrations in amniotic fluid: correlation with intra-amniotic infection and bacterial inhibitory activity.
    Gibbs RS; Blanco JD; Hnilica VS
    Am J Obstet Gynecol; 1982 May; 143(2):163-6. PubMed ID: 7081327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine conjugates and total polyamine concentrations in human amniotic fluid.
    Chan WY; Seale TW; Shukla JB; Rennert OM
    Clin Chim Acta; 1979 Feb; 91(3):233-41. PubMed ID: 761399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical assessment of antibacterial properties of human amniotic fluid.
    Larsen B; Davis B; Charles D
    Gynecol Obstet Invest; 1984; 18(2):100-4. PubMed ID: 6383963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.